Medidata allies with Apple; Danaher snags Pall for $13.8B;

> Medidata ($MDSO) has connected its eClinical platform to Apple's ($AAPL) ResearchKit. News

> Danaher is buying Pall ($PLL) for $13.8 billion with an eye on the fast-growing world of biopharma services. Story

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.